Genesis Biomedical, page-2

hi, i bought in at a much higher price when i thought they had real potential. they have now sold off what i regarded as their best growth potential i.e. bodyworks. however, buying in at these prices you should be pretty safe, as they now have $7m in the kitty (proceeds from the sale of bodyworks) with which to proceed with commercialising cellgen. the clinical trial results are due out at the end of this month. if these are positive you should make some reasonable returns. i would expect the share price to make it back up to around 8-9c on positive trial results.